Hunt Jonathan Robert
Chief Accounting Officer
Hunt Jonathan Robert has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 17, 2025.
On the most recent filing, Hunt Jonathan Robert is listed as Chief Accounting Officer at Perspective Therapeutics, Inc. Inside the rolling window, Hunt Jonathan Robert reported 1 open-market purchase totaling $22K in CATX and no open-market sales.
Companies traded
Other insiders at CATX
Insider Buying
$22K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hunt Jonathan Robert made?
Hunt Jonathan Robert has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Hunt Jonathan Robert trade?
Hunt Jonathan Robert has filed SEC Form 4 disclosures for 1 company, including CATX.
When was Hunt Jonathan Robert's most recent SEC Form 4 filing?
Hunt Jonathan Robert's most recent SEC Form 4 filing on Tracefour is dated Nov 17, 2025.
What is Hunt Jonathan Robert's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hunt Jonathan Robert is listed as Chief Accounting Officer.
What is Hunt Jonathan Robert's total buy and sell value in the current window?
Inside the rolling retention window, Hunt Jonathan Robert bought $22K and sold $0 based on SEC Form 4 filings.
What was Hunt Jonathan Robert's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 11,000 CATX shares on 2025-11-13, worth $22K, per SEC Form 4 filings.